Lonafarnib and Defactinib: Interaction Details
- Lonafarnib
- Zokinvy
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Lonafarnib and Defactinib interaction:
Defactinib
We don't have a drug information page for Defactinib yet. Have a question about Defactinib? Ask a pharmacist, free →
What Happens When You Take Lonafarnib With Defactinib
What can happen when they are taken together (rated Major)
Increased defactinib exposure and an increased risk of defactinib-related adverse effects
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Defactinib is a , and it should not be taken together with strong or moderate . When inhibitors are co-administered, defactinib exposure rises, which can raise the likelihood of adverse reactions to defactinib.
A drug interaction study tested defactinib with itraconazole (a strong CYP3A ) at 200 mg daily for 10 days. Under these conditions, defactinib was 2.2-fold higher and was 3.9-fold higher. For M4, AUC rose 2.2-fold while Cmax fell by 6.8%.1
The Lonafarnib and Defactinib Interaction, Explained
Lonafarnib can raise the level of defactinib in your body. Your body breaks down defactinib using an enzyme called , and lonafarnib slows that enzyme down. With less breakdown, more defactinib stays in your system, which can make side effects more likely or stronger.
In a study with a different strong enzyme blocker, defactinib levels rose to nearly four times higher. Please keep taking both medicines as prescribed and talk with your pharmacist or doctor. Your care team can manage this, for example by choosing a different plan or watching you more closely.
Mechanism: Lonafarnib inhibits , and defactinib is a CYP3A4 . reduces defactinib and raises exposure. Neither drug's activity depends on activation in a way that changes this direction.
- Magnitude (itraconazole, strong ): defactinib 2.2-fold, 3.9-fold; M4 AUC 2.2-fold, Cmax decreased 6.8%.
- Effect: increased risk of defactinib adverse reactions.
- Onset: unspecified. Evidence: probable (extrapolated from the itraconazole study).
- Management: avoid of defactinib with strong or moderate CYP3A . If coadministration is considered necessary, individualize therapy and monitor closely for defactinib toxicity.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Lonafarnib and Defactinib Interact
The likely mechanism
of -mediated of defactinib
How to Manage the Lonafarnib and Defactinib Interaction
The documented advice is to avoid using defactinib together with strong or moderate , because they raise defactinib levels and the chance of side effects.
- Keep taking both medicines as prescribed until your care team tells you otherwise.
- Do not stop or change either medicine on your own.
- Ask your pharmacist or prescriber to review this combination, including whether another option fits your treatment.
- If both are needed, your team may individualize the dose and monitor you more closely.
- Report any new or worsening side effects promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Lonafarnib or Defactinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: AVMAPKI FAKZYNJA CO-PACK oral capsules, tablets, avutometinib oral capsules, defactinib oral tablets
In a drug interaction study, of defactinib with itraconazole (a strong ) at 200 mg daily for 10 days raised defactinib 2.2-fold and 3.9-fold. For N-desmethyl amide (M4), the major of defactinib, AUC rose 2.2-fold while Cmax fell by 6.8%.1
Lonafarnib and Defactinib: Common Questions
How serious is the Lonafarnib and Defactinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Lonafarnib and Defactinib interaction managed?
The documented advice is to avoid using defactinib together with strong or moderate , because they raise defactinib levels and the chance of side effects. Keep taking both medicines as prescribed until your care team tells you otherwise. Do not stop or change either medicine on your own. Ask your pharmacist or prescriber to review this combination, including whether another option… Management is individual — always follow your own care team's guidance.
Does taking Lonafarnib and Defactinib at different times of day help?
No. Taking them at different times of day does not prevent this one. Lonafarnib slows , an enzyme that breaks down defactinib, so defactinib can build up in the body. That change lasts while lonafarnib is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Lonafarnib and Defactinib Interaction
Ask in your own words about taking Lonafarnib and Defactinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: AVMAPKI(TM) FAKZYNJA(TM) CO-PACK oral capsules, tablets, avutometinib oral capsules, defactinib oral tablets. Verastem, Inc (per manufacturer), Needham, MA, 2025. DailyMed
Other Serious Interactions of Lonafarnib and Defactinib
Also serious with Lonafarnib
- ColchicineContraindicated
- SimvastatinContraindicated
- AtorvastatinContraindicated
- Dihydroergotamine InjectionContraindicated
Also serious with Defactinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Lonafarnib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- AsarabaccaMajor
- Siberian CockleburMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- + 157 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.